Clinical Trials Browser

HER2-mutant Non-Small Cell Lung Cancer × trastuzumab deruxtecan × 1 year × Clear all

NCT05246514 2025-08-28

DL-05

Phase 2 Active not recruiting

72 enrolled 16 charts

HER2-mutant Non-Small Cell Lung Cancer